A growing number of doctors across a range of specialties have eschewed routine patient weigh-ins, an approach aimed at ...

Starting in the new year, Independence Blue Cross, the region’s largest health insurer, will no longer cover anti-obesity drugs like Ozempic and Wegovy when they’re prescribed solely for weight loss.

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

Can simple diet and lifestyle changes keep your brain healthy? Do you have the power to prevent Alzheimer’s disease and ...

For a healthy heart, the best breakfast is one that provides 20% to 30% of daily calorie intake, while wating either less or ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

A recent study from Johns Hopkins Medicine has found that a drug originally developed to treat Alzheimer’s disease, ...

The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...

Science confirms that consuming 20% to 30% of daily calories in the morning improves cardiovascular health and controls ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...